Recent clinical studies showed that survival of chronic lymphocytic leukaemia (CLL) is largely dependent on BCL2 [21], and that loss of a single Bclx allele attenuates MYC-induced lymphoma in vivo [23]. Here, BCL2 is linked to lymphoma.